We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Dade Behring Obtains Rights to Cardiac Markers

By HospiMedica staff writers
Posted on 28 Jun 2005
An exclusive licensing agreement provides Dade Behring (Deerfield, IL, USA) with the worldwide exclusive rights to the combined use of soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PLGF) for the diagnosis of vascular diseases, an invention of Professor Zeiher and his group at the University of Frankfurt (Germany).

The license was granted by the University of Frankfurt and Innovectis (also in Frankfurt), a company that manages technology services for the university. More...
The combination of sFlt-1 and PLGF are important for the prognosis of patients with angina pectoris and following a heart attack.

PLGF is a primary inflammatory instigator of atherosclerotic plaque instability. However, sFlt-1 has been found to capture PLGF, which appears to inhibit this activity. Recent studies by Prof. Zeiher and his group show that the combination of these markers is a powerful independent predictor of adverse outcomes for patients after angina pectoris or heart attack. An immediate and accurate diagnosis of patients is necessary in order to help doctors provide the best treatment.

"As a leader in the cardiac marketplace, we are committed to conducting research and development of new methods that will continue to expand the determining factors of cardiac episodes,” remarked Jim Reid-Anderson, chairman, president, and CEO of Dade Behring.

"This license agreement is an expression of the close connection between basic research in medicine and the development of diagnostic tools in industry,” said Jurgen Bereiter-Hahn, vice president of the University of Frankfurt and chairman of Innovectis.



Related Links:
Dade Behring
Innovectis
U. of Frankfurt

New
Gold Member
Hematology Analyzer
Medonic M32B
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Pancreas cells (left) showing early stages of malignant cancer in brown and same cells stained blue (right) indicate they are Integrin β3 (ITGB3) positive (Photo courtesy of UC San Diego Health Sciences)

Gene Signature Could Serve as Early Warning System for Aggressive Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal forms of cancer, with early detection remaining a major challenge. Precancerous cells must overcome significant stress and... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.